Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020

Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, William T., Howell, J. Christina, Ozturk, Tugba, Benameur, Karima, Bassit, Leda C., Ramonell, Richard, Cashman, Kevin S., Pirmohammed, Shama, Roback, John D., Marconi, Vincent C., Yang, Irene, Mac, Valerie V., Smith, Daniel, Sanz, Ignacio, Wharton, Whitney, Lee, F. Eun-Hyung, Schinazi, Raymond F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706962/
https://www.ncbi.nlm.nih.gov/pubmed/32857691
http://dx.doi.org/10.3201/eid2612.203334
Descripción
Sumario:Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.

Ejemplares similares